{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:22:53Z","timestamp":1790752973616,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.path.2019.08.005","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T21:20:03Z","timestamp":1569619203000},"page":"967-995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["A Diagnostic Approach to Adrenocortical Tumors"],"prefix":"10.1016","volume":"12","author":[{"given":"Anjelica","family":"Hodgson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pakbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2019.08.005_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2016.00051","article-title":"Editorial: adrenal cortex: from physiology to disease","volume":"7","author":"Val","year":"2016","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.path.2019.08.005_bib2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"Clinical practice. The incidentally discovered adrenal mass","volume":"356","author":"Young","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2019.08.005_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000105811","article-title":"Precursor lesions of the adrenal gland","volume":"74","author":"van Nederveen","year":"2007","journal-title":"Pathobiology"},{"key":"10.1016\/j.path.2019.08.005_bib4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/PAT.0b013e32835f45c5","article-title":"Precursor lesions of endocrine system neoplasms","volume":"45","author":"Mete","year":"2013","journal-title":"Pathology"},{"key":"10.1016\/j.path.2019.08.005_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/PAP.0000000000000019","article-title":"Adrenocortical carcinoma: review and update","volume":"21","author":"Erickson","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib6","series-title":"Endocrine pathology","first-page":"602","article-title":"Adrenal cortical proliferations","author":"Duan","year":"2016"},{"key":"10.1016\/j.path.2019.08.005_bib7","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.005_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jc.2014-3663","article-title":"Update in primary aldosteronism","volume":"100","author":"Stowasser","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.005_bib9","doi-asserted-by":"crossref","first-page":"948","DOI":"10.5858\/arpa.2014-0156-RS","article-title":"Clinicopathologic correlates of primary aldosteronism","volume":"139","author":"Duan","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2019.08.005_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/jclinpath-2014-202612","article-title":"Clinicopathological correlates of adrenal Cushing\u2019s syndrome","volume":"68","author":"Duan","year":"2015","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib11","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"El-Maouche","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.path.2019.08.005_bib12","series-title":"Molecular and Cellular Endocrine Pathology","first-page":"221","article-title":"The adrenal cortex","author":"Sasano","year":"2000"},{"key":"10.1016\/j.path.2019.08.005_bib13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7326\/0003-4819-138-5-200303040-00013","article-title":"Management of the clinically inapparent adrenal mass (\u2018incidentaloma\u2019)","volume":"138","author":"Grumbach","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.path.2019.08.005_bib14","first-page":"102","article-title":"Distinguishing benign from malignant adrenal masses","volume":"3","author":"Francis","year":"2003","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.path.2019.08.005_bib15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ecl.2005.04.006","article-title":"Diagnostic imaging of the thyroid and adrenal glands in childhood","volume":"34","author":"Daneman","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.path.2019.08.005_bib16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00004728-199109000-00009","article-title":"CT and MR imaging of massive macronodular adrenocortical disease: a rare cause of autonomous primary adrenal hypercortisolism","volume":"15","author":"Doppman","year":"1991","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.path.2019.08.005_bib17","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1210\/jc.2015-2174","article-title":"Hormonal, radiological, NP-59 scintigraphy, and pathological correlations in patients with cushing\u2019s syndrome due to primary pigmented nodular adrenocortical disease (PPNAD)","volume":"100","author":"Vezzosi","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.005_bib18","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1210\/jc.2009-0031","article-title":"The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits","volume":"94","author":"Louiset","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.005_bib19","article-title":"Targeted molecular imaging in adrenal disease-an emerging role for metomidate PET-CT","volume":"6","author":"Mendichovszky","year":"2016","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.path.2019.08.005_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/cen.13942","article-title":"11 C-Metomidate PET\/CT is a useful adjunct for lateralisation of primary aldosteronism in routine clinical practice","author":"O\u2019Shea","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.path.2019.08.005_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2214\/ajr.179.3.1790559","article-title":"Imaging of adrenal incidentalomas: current status","volume":"179","author":"Dunnick","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.path.2019.08.005_bib22","series-title":"Diseases of the abdomen and pelvis 2018-2021","first-page":"85","article-title":"Adrenal imaging","author":"Francis","year":"2018"},{"key":"10.1016\/j.path.2019.08.005_bib23","first-page":"196","article-title":"Laparoscopic surgery for malignant adrenal tumors","volume":"13","author":"Zografos","year":"2009","journal-title":"JSLS"},{"key":"10.1016\/j.path.2019.08.005_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12022-008-9055-x","article-title":"A\u00a0diagnostic approach to adrenal cortical lesions","volume":"19","author":"McNicol","year":"2008","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1365-2559.2011.04141.x","article-title":"Morphological distinction of cortisol-producing and aldosterone-producing adrenal cortical adenomas: not only possible but a critical clinical responsibility","volume":"60","author":"Mete","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2019.08.005_bib26","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/00000478-200212000-00009","article-title":"Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors","volume":"26","author":"Aubert","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib27","series-title":"WHO classification of tumours of endocrine organs","author":"Lloyd","year":"2017"},{"key":"10.1016\/j.path.2019.08.005_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fmed.2018.00054","article-title":"The many faces of primary aldosteronism and cushing syndrome: a reflection of adrenocortical tumor heterogeneity","volume":"5","author":"Mete","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.path.2019.08.005_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1746-1596-9-147","article-title":"Adrenal gland inclusions in patients treated with aldosterone antagonists (Spironolactone\/Eplerenone): incidence, morphology, and ultrastructural findings","volume":"9","author":"Patel","year":"2014","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PAS.0000000000000748","article-title":"Cushing syndrome in carney complex: clinical, pathologic, and molecular genetic findings in the 17 affected mayo clinic patients","volume":"41","author":"Lowe","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib31","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/ncpendmet0648","article-title":"Genetics of adrenal tumors associated with Cushing\u2019s syndrome: a new classification for bilateral adrenocortical hyperplasias","volume":"3","author":"Stratakis","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.005_bib32","doi-asserted-by":"crossref","first-page":"E202","DOI":"10.1210\/jc.2011-2321","article-title":"Carney complex with adrenal cortical carcinoma","volume":"97","author":"Morin","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.005_bib33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2011-2244","article-title":"A\u00a0large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer","volume":"97","author":"Anselmo","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.005_bib34","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1097\/PAS.0b013e31822da401","article-title":"Oncocytic adrenocortical tumors: diagnostic algorithm and mitochondrial DNA profile in 27 cases","volume":"35","author":"Duregon","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib35","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41379-018-0077-8","article-title":"Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation","volume":"31","author":"Renaudin","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","author":"Weiss","year":"1984","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","article-title":"Pathologic features of prognostic significance in adrenocortical carcinoma","volume":"13","author":"Weiss","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/106689690401200304","article-title":"Adrenocortical oncocytic tumors: report of 10 cases and review of the literature","volume":"12","author":"Bisceglia","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2559.2009.03423.x","article-title":"Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification","volume":"55","author":"Volante","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2019.08.005_bib40","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/PAS.0b013e31828d387b","article-title":"The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases","volume":"37","author":"Duregon","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PAS.0000000000000943","article-title":"Diagnostic and prognostic biomarkers of adrenal cortical carcinoma","volume":"42","author":"Mete","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib42","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4103\/ijem.IJEM_573_16","article-title":"Diagnosis of adrenocortical tumors by reticulin algorithm","volume":"21","author":"Fonseca","year":"2017","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.005_bib43","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/PAS.0b013e3181e2b726","article-title":"Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior","volume":"34","author":"Papotti","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1507\/endocrj.K07-079","article-title":"Immunohistochemistry of a proliferation marker Ki67\/MIB1 in adrenocortical carcinomas: Ki67\/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas","volume":"55","author":"Morimoto","year":"2008","journal-title":"Endocr J"},{"key":"10.1016\/j.path.2019.08.005_bib45","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.humpath.2014.11.015","article-title":"Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas","volume":"46","author":"Pennanen","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2016.09.035","article-title":"Validation of the prognostic role of the \u2018Helsinki Score\u2019 in 225 cases of adrenocortical carcinoma","volume":"62","author":"Duregon","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2015.00023","article-title":"Pediatric adrenocortical tumors: what they can tell us on adrenal development and comparison with adult adrenal tumors","volume":"6","author":"Lalli","year":"2015","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.path.2019.08.005_bib48","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00000478-200307000-00001","article-title":"Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients","volume":"27","author":"Wieneke","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib49","article-title":"Revisiting the role of the pathological grading in pediatric adrenal cortical tumors: results from a national cohort study with pathological review","author":"Picard","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib50","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jpedsurg.2016.07.014","article-title":"Weineke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors: Is there a correlation?","volume":"51","author":"Das","year":"2016","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.path.2019.08.005_bib51","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00383-015-3708-x","article-title":"Usefulness of Wieneke criteria in assessing morphologic characteristics of adrenocortical tumors in children","volume":"31","author":"Chatterjee","year":"2015","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.path.2019.08.005_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12022-018-9525-8","article-title":"Immunohistochemical biomarkers of adrenal cortical neoplasms","volume":"29","author":"Mete","year":"2018","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib53","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.path.2019.08.005_bib54","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00423-010-0698-y","article-title":"Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade","volume":"395","author":"Miller","year":"2010","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.path.2019.08.005_bib55","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2006-0706","article-title":"Prognostic parameters of metastatic adrenocortical carcinoma","volume":"92","author":"Assi\u00e9","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.005_bib56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/PAS.0b013e31820bcf21","article-title":"The argument for mitotic rate-based grading for the prognostication of adrenocortical carcinoma","volume":"35","author":"Giordano","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib57","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.humpath.2015.08.012","article-title":"Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases","volume":"46","author":"Duregon","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.humpath.2016.08.006","article-title":"Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis","volume":"58","author":"Papathomas","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib59","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2559.2006.02505.x","article-title":"IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours","volume":"49","author":"Schmitt","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2019.08.005_bib60","first-page":"790","article-title":"p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies","volume":"78","author":"Reincke","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.005_bib61","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.2013.52.6863","article-title":"Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children\u2019s oncology group study","volume":"33","author":"Wasserman","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2019.08.005_bib62","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00423-011-0868-6","article-title":"Clinical impact of TP53 alterations in adrenocortical carcinomas","volume":"397","author":"Waldmann","year":"2012","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.path.2019.08.005_bib63","doi-asserted-by":"crossref","first-page":"R215","DOI":"10.1530\/EJE-18-0027","article-title":"Management of endocrine disease: adrenocortical carcinoma: differentiating the good from the poor prognosis tumors","volume":"178","author":"Jouinot","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.path.2019.08.005_bib64","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1200\/JCO.2008.18.5678","article-title":"Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival","volume":"27","author":"de Reyni\u00e8s","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2019.08.005_bib65","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1158\/1078-0432.CCR-08-1067","article-title":"Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling","volume":"15","author":"Giordano","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.path.2019.08.005_bib66","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/modpathol.2013.230","article-title":"Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma","volume":"27","author":"Duregon","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib67","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.path.2019.08.005_bib68","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/PAS.0000000000000574","article-title":"An international Ki67 reproducibility study in adrenal cortical carcinoma","volume":"40","author":"Papathomas","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib69","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13000-014-0216-6","article-title":"Automated Selection of Hotspots (ASH): enhanced automated segmentation and adaptive step finding for Ki67 hotspot detection in adrenal cortical cancer","volume":"9","author":"Lu","year":"2014","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib70","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.005_bib71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.humpath.2015.10.017","article-title":"Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis","volume":"53","author":"Yamazaki","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib72","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.1207313","article-title":"Altered telomeres in tumors with ATRX and DAXX mutations","volume":"333","author":"Heaphy","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.path.2019.08.005_bib73","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/jclinpath-2014-202514","article-title":"Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies","volume":"67","author":"Ross","year":"2014","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.path.2019.08.005_bib74","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MED.0000000000000248","article-title":"Immunohistochemistry of the adrenal in primary aldosteronism","volume":"23","author":"Gomez-Sanchez","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.path.2019.08.005_bib75","first-page":"1182","article-title":"Histopathological classification of cross-sectional image-negative hyperaldosteronism","volume":"102","author":"Yamazaki","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.005_bib76","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0039-6060(05)80117-5","article-title":"Adrenal lesion in multiple endocrine neoplasia type 1","volume":"118","author":"Skogseid","year":"1995","journal-title":"Surgery"},{"key":"10.1016\/j.path.2019.08.005_bib77","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/86.22.1707","article-title":"High frequency of germline p53 mutations in childhood adrenocortical cancer","volume":"86","author":"Wagner","year":"1994","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.path.2019.08.005_bib78","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/BF02236860","article-title":"Adrenal masses are associated with familial adenomatous polyposis","volume":"43","author":"Smith","year":"2000","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.path.2019.08.005_bib79","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1200\/JCO.2012.48.0988","article-title":"Adrenocortical carcinoma is a lynch syndrome-associated cancer","volume":"31","author":"Raymond","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2019.08.005_bib80","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/EJE-17-0358","article-title":"Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series","volume":"177","author":"Else","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.path.2019.08.005_bib81","first-page":"140074","article-title":"Adrenal cancer in neurofibromatosis type 1: case report and DNA analysis","volume":"2014","author":"Menon","year":"2014","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.path.2019.08.005_bib82","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00279003","article-title":"Molecular definition of the 11p15.5 region involved in Beckwith-Wiedemann syndrome and probably in predisposition to adrenocortical carcinoma","volume":"81","author":"Henry","year":"1989","journal-title":"Hum Genet"},{"key":"10.1016\/j.path.2019.08.005_bib83","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/js.2017-00134","article-title":"Aldosterone-producing cell clusters frequently harbor\u00a0somatic mutations and accumulate with age in normal adrenals","volume":"1","author":"Omata","year":"2017","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.path.2019.08.005_bib84","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and genetic causes of idiopathic hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.path.2019.08.005_bib85","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.mce.2014.09.015","article-title":"Understanding primary aldosteronism: impact of next generation sequencing and expression profiling","volume":"399","author":"Monticone","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.path.2019.08.005_bib86","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fendo.2016.00075","article-title":"Intracellular molecular differences in aldosterone- compared to cortisol-secreting adrenal cortical adenomas","volume":"7","author":"Seidel","year":"2016","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.path.2019.08.005_bib87","doi-asserted-by":"crossref","first-page":"e41926","DOI":"10.1371\/journal.pone.0041926","article-title":"Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter","volume":"7","author":"\u00c5kerstr\u00f6m","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.path.2019.08.005_bib88","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/HYPERTENSIONAHA.117.09057","article-title":"Aldosterone-producing adenomas: histopathology-genotype correlation and identification of a novel CACNA1D mutation","volume":"70","author":"Tan","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.path.2019.08.005_bib89","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/jc.2015-3239","article-title":"Molecular heterogeneity in aldosterone-producing adenomas","volume":"101","author":"Nanba","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.005_bib90","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrendo.2016.24","article-title":"A\u00a0genetic and molecular update on adrenocortical causes of Cushing syndrome","volume":"12","author":"Lodish","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.path.2019.08.005_bib91","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98296","article-title":"Activating PRKACB somatic mutation in cortisol-producing adenomas","volume":"3","author":"Espiard","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.path.2019.08.005_bib92","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/a-0753-4943","article-title":"Carney complex","volume":"127","author":"Kamilaris","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.path.2019.08.005_bib93","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fendo.2016.00111","article-title":"Alterations of Phosphodiesterases in Adrenocortical Tumors","volume":"7","author":"Hannah-Shmouni","year":"2016","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.path.2019.08.005_bib94","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing\u2019s syndrome","volume":"369","author":"Assi\u00e9","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2019.08.005_bib95","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1507\/endocrj.K10E-218","article-title":"A\u00a0case of ACTH-independent macronodular adrenal hyperplasia associated with multiple endocrine neoplasia type 1","volume":"58","author":"Yoshida","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/j.path.2019.08.005_bib96","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/1078-0432.CCR-08-0106","article-title":"Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors","volume":"14","author":"Lib\u00e9","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.path.2019.08.005_bib97","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/jc.2004-2377","article-title":"Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigation","volume":"90","author":"Matyakhina","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.005_bib98","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1210\/jc.2009-0516","article-title":"Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors","volume":"94","author":"Hsiao","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.005_bib99","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1158\/1078-0432.CCR-10-1497","article-title":"Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers","volume":"16","author":"Gaujoux","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.path.2019.08.005_bib100","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1038\/ncomms7302","article-title":"Genomic landscape of paediatric adrenocortical tumours","volume":"6","author":"Pinto","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.path.2019.08.005_bib101","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.path.2019.08.005_bib102","doi-asserted-by":"crossref","first-page":"E493","DOI":"10.1210\/jc.2014-3282","article-title":"Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma","volume":"100","author":"Juhlin","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.005_bib103","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1038\/s41467-018-06366-z","article-title":"Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors","volume":"9","author":"Gara","year":"2018","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.path.2019.08.005_bib104","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1158\/1078-0432.CCR-18-2693","article-title":"Targeted assessment of G0S2 methylation identifies a rapidly recurrent, routinely fatal molecular subtype of adrenocortical carcinoma","volume":"25","author":"Mohan","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.path.2019.08.005_bib105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/EJE-11-0806","article-title":"Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients","volume":"166","author":"Fragoso","year":"2012","journal-title":"Eur J Endocrinol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:39:41Z","timestamp":1761748781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918119300613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1875918119300613"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2019.08.005","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Diagnostic Approach to Adrenocortical Tumors","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2019.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}